Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Bryan Giraudo Biography and Net Worth

CFO of Gossamer Bio

Mr. Giraudo is the Chief Financial Officer of Gossamer Bio. Previously, he was Senior Managing Director at LEERINK Partners, where he was responsible for LEERINK’s Western North America and Asia life sciences investment banking practice. Prior to joining LEERINK Partners in 2009, Bryan was a Managing Director in Merrill Lynch’s Global Healthcare Investment Banking Group. Bryan received his B.A. from Georgetown University.

What is Bryan Giraudo's net worth?: The estimated net worth of Bryan Giraudo is at least $64,591.32 as of March 27th, 2024. Mr. Giraudo owns 92,737 shares of Gossamer Bio stock worth more than $64,591 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Giraudo may own. Additionally, Mr. Giraudo receives an annual salary of $708,090.00 as CFO at Gossamer Bio. Learn More about Bryan Giraudo's net worth.
How old is Bryan Giraudo?: Mr. Giraudo is currently 49 years old. There are 5 older executives and no younger executives at Gossamer Bio. The oldest executive at Gossamer Bio is Mr. Faheem Hasnain, Co-Founder, CEO, President & Chairman, who is 66 years old. Learn More on Bryan Giraudo's age.
What is Bryan Giraudo's salary?: As the CFO of Gossamer Bio, Inc., Mr. Giraudo earns $708,090.00 per year. The highest earning executive at Gossamer Bio is Mr. Faheem Hasnain, Co-Founder, CEO, President & Chairman, who commands a salary of $910,260.00 per year. Learn More on Bryan Giraudo's salary.
How do I contact Bryan Giraudo?: The corporate mailing address for Mr. Giraudo and other Gossamer Bio executives is 3013 SCIENCE PARK, SAN DIEGO CA, 92121. Gossamer Bio can also be reached via phone at (858) 684-1300 and via email at [email protected]. Learn More on Bryan Giraudo's contact information.
Has Bryan Giraudo been buying or selling shares of Gossamer Bio?: Bryan Giraudo has not been actively trading shares of Gossamer Bio during the last quarter. Most recently, Bryan Giraudo sold 6,430 shares of the business's stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $1.16, for a transaction totalling $7,458.80. Following the completion of the sale, the chief financial officer now directly owns 92,737 shares of the company's stock, valued at $107,574.92. Learn More on Bryan Giraudo's trading history.
Who are Gossamer Bio's active insiders?: Gossamer Bio's insider roster includes Laura Carter (Insider), Bryan Giraudo (CFO), and Luisa Salter-Cid (Insider). Learn More on Gossamer Bio's active insiders.
Are insiders buying or selling shares of Gossamer Bio?: During the last year, Gossamer Bio insiders bought shares 1 times. They purchased a total of 372,000 shares worth more than $249,240.00. During the last year, insiders at the sold shares 4 times. They sold a total of 35,528 shares worth more than $40,941.54. The most recent insider tranaction occured on June, 24th when insider Richard Aranda sold 1,908 shares worth more than $1,259.28. Insiders at Gossamer Bio own 5.0% of the company. Learn More about insider trades at Gossamer Bio.
Information on this page was last updated on 6/24/2024.

Bryan Giraudo Insider Trading History at Gossamer Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2024	Sell	6,430	$1.16	$7,458.80	92,737
11/13/2023	Buy	200,000	$0.56	$112,000.00	380,010
4/4/2023	Buy	55,000	$1.02	$56,100.00	125,990
3/20/2023	Buy	50,000	$0.97	$48,500.00	70,990
7/15/2022	Buy	13,869	$7.21	$99,995.49	20,990
3/23/2021	Sell	5,490	$9.48	$52,045.20	109,889
10/14/2020	Buy	3,000	$10.01	$30,030.00
6/23/2020	Buy	2,000	$12.96	$25,920.00
9/26/2019	Buy	1,121	$16.78	$18,810.38
5/30/2019	Buy	1,000	$18.70	$18,700.00
2/12/2019	Buy	6,000	$16.00	$96,000.00

Bryan Giraudo Buying and Selling Activity at Gossamer Bio

Gossamer Bio Company Overview

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Today's Range

Now: $0.70

$0.68

$0.72

50 Day Range

MA: $0.92

$0.71

$1.07

2 Week Range

Now: $0.70

$0.50

$1.60

Volume

1,005,125 shs

Average Volume

1,427,142 shs

Market Capitalization

$157.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Breaking News: Tesla headed to $500…

From WealthPress | Ad

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Bryan Giraudo Biography and Net Worth

What is Bryan Giraudo's net worth?

How old is Bryan Giraudo?

What is Bryan Giraudo's salary?

How do I contact Bryan Giraudo?

Has Bryan Giraudo been buying or selling shares of Gossamer Bio?

Who are Gossamer Bio's active insiders?

Are insiders buying or selling shares of Gossamer Bio?